Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
More Fluff, Most Likely...
Xalles Holdings Inc. will post its latest financial statements and annual report this week on OTC Markets. A series of subsequent tweets will summarize key parts of the business operations, the improved Q4 results, and a look ahead to Q1 performance. $XALL
Xalles Holdings Inc. will post its latest financial statements and annual report this week on OTC Markets. A series of subsequent tweets will summarize key parts of the business operations, the improved Q4 results, and a look ahead to Q1 performance. $XALL#fintech pic.twitter.com/9lYOf02ii0
— Xalles (@xalles1) March 14, 2022
Thomas O. Nash January 27, 1924 - February 20, 2022
Is this our Thomas Nash ?
This could explain everything.
https://www.memorialparkfuneralandcemetery.com/obituaries/Thomas-Nash-7/#!/PhotosVideos/9550d15c-9126-429d-bf06-c02c9c672a6d/f9ab6b11-1764-4cac-986b-d5336ef0c8c8
https://patents.justia.com/inventor/mark-k-gaalswyk
Hey HD,
"Glad I didn’t put 500 k on the bid"
You are a buyer today? Last week you were threatening to sell 29 M.
You sure make me smile....
There are 147 shareholders / Investors / Traders in XALL.
#4 is nearly impossible.
4. As per usual trading rules, he/she must be the ONLY PERSON trading Xalles under the sticker CDEL.
Any Investor / Trader that doesn't work a portion of their position is losing money on a daily basis.
The only reason that XALL is where it is is because any news the company comes out with is Fluff. This gives Investors / Traders the opportunity to trade their shares.
Remember, Buy Low, Sell High equals Profits. Whether it be 5% or 100%.
Slim....
So you are saying you will pay me $5,000 for the ID of the investor / trader that has been trading XALL under CDEL?
Grab them HD.... Mil + for you
Cash Purchase Restricted Shares
listed under Item 3. Issuance History, are shares bought through the company by investors at a discount to fund the company.
Patents held by CEO Mark K. Gaalswyk
https://patents.justia.com/inventor/mark-k-gaalswyk
Xalles Studio connects early-stage technology
What a joke Bud. The company can't even connect to the internet....
"Coming Soon" Now for a week shy of (4) FOUR, can you believe it FOUR MONTHS.
UNBELIEVABLE...
What company would want to do business with a company that can't get a website up.
"The reverse stock split, for which we are awaiting FINRA approval, is a proactive measure that we believe will better position us for success, and ultimately generate value for all of the Company’s stockholders. The ultimate aim is to raise our stock’s visibility within the investment community by improving long-term liquidity and creating a trading environment attractive to institutional investors"
https://www.marketwatch.com/press-release/appyea-takes-steps-for-future-growth-2021-11-16
Xalles leveraging GioBot will give our customers the edge they need to maximize their capital return potential in this rapidly evolving cryptocurrency environment. $XALL
Xalles leveraging GioBot will give our customers the edge they need to maximize their capital return potential in this rapidly evolving cryptocurrency environment. $XALL #Crypto #Trading pic.twitter.com/96BauohRt8
— Xalles (@xalles1) December 15, 2021
Xalles Studio business model includes creating a portfolio of minority ownership stakes
Help Wanted - Xalles Holdings Inc.
Looking for an experienced web designer.
Web designers plan, create and code internet sites and web pages, many of which combine text with sounds, pictures, graphics and video clips. A web designer is responsible for creating the design and layout of a website or web pages. It and can mean working on a brand new website or updating an already existing site.
Disclaimer: The above is purely for entertainment purposes...
HD...
Yes, I read through all the posts. I am being reserved to the idea of connections to FLAG as Nash is on several boards, ie, Plymouth.
I am in a wait and see mode. As stated before, FLAG, being an upper exchange company lends credibility to Nash being on the board.
OTC companies put anybody on the boards, however, that generally doesn't hold true for higher exchange companies.
This tells me Nash is respected.
First Light Acquisition Group, Inc. (FLAG)
NYSE - Nasdaq Real Time Price. Currency in USD
FLAG does not trade on the OTC. NYSE is a completely different exchange. Hence no MM manipulation...
Xalles Affiliate? Submitted: 2021-09-13 $200,000,000 First Light Acquisition Group, Inc
Nice find HD
This could be interesting. And could explain the long delayed announcements and silence from the company.
Nash being an advisor to an upcoming IPO lends credibility.
First Light Acquisition Group, Inc. is a newly incorporated blank check company whose business purpose is to effect a merger
This is an initial public offering of our securities. Each unit has an offering price of $10.00
https://sec.report/Document/0001193125-21-271636/
My question is does Harry get named CSO before or after the $50M for the acquisition gets announced...
Everything is speculation at this point. My guess is Regen will get the money from Lilly and Regen will buy Canary.
It may come as payment for IP access.
But the honest truth, I do not know. It's beyond my scope... :))
It is Old News, However....And the $50M Question...
I specifically highlighted in BOLD that Harry Lander,CEO and Managing Partner of Canary was in the past the CSO of Regen.
As stated in the 8K dated 9-24, One of Koos goals going forward was to hire a CSO.
The former CSO is now the CEO of the acquisition target.
The $50M Question.RGBP and LLY
LILLY ENDOWMENT INC sold off 195,000 shares out of their $29B fund on November 4th. The value of the 195,000 shares just happens to add up to $50M+
The amount that is needed for the deal to happen.
https://www.sec.gov/Archives/edgar/data/59478/000120919121063054/xslF345X03/doc4.xml
Harry Lander, Ph.D., MBA, President and Chief Scientific Officer of Regen BioPharma, Inc.
SAN DIEGO, June 30, 2016 /PRNewswire/ --
Regen BioPharma, Inc., (OTCQB: RGBP) and (OTCQB: RGBPP) has entered into a definitive agreement with Eli Lilly and Company which allows Regen to receive compounds from Lilly for drug discovery purposes and allows Regen to share structural information on compounds of mutual interest.
The agreement also grants to Lilly an option to negotiate an agreement with Regen including but not restricted to a compound purchase agreement, a license agreement, or a research collaboration agreement for further research and development of material of mutual interest.
"Lilly's Open Innovation Drug Discovery Program is visionary," said Harry Lander, Ph.D., MBA, President and Chief Scientific Officer of Regen BioPharma, Inc. "They understand the value of partnering in a confidential manner with smaller entities that may have intellectual property that aligns with their product goals."
https://www.prnewswire.com/news-releases/regen-biopharma-inc-enters-into-open-innovation-drug-discovery-program-agreement-with-eli-lilly-and-company-585014641.html
The Arctic Fox
Doyon and all the other Drilling contractors on the Slope get paid on a "Day Rate". Highly unlikely there will be any payment in shares....
https://www.doyondrilling.com/our-rigs/arctic-fox/
-20 Temps are ideal for building ice roads. January is the start of "Ice" season where the roads get built to go out on the ice for exploratory work.
Skiluc...
Several ways to read into the wording of the 8K, specifically (Pursuant to such interpretation the noteholders may have been able to convert the outstanding balances over time into 855,584,615 shares of the Company’s common stock having an aggregate value of $16,598,341 (valued at the closing price of the Company’s common shares as of October 21, 2021) such conversions being permitted so long as any one such conversion would not result in the noteholder holding over 9.9% of the Company’s common shares.)
Personally, I believe that this is all great and is a another mark going in the right direction.
In the last 3 weeks we have traded 1,077,399,565 shares and we have gone down solid for 5 weeks now.
If these note holders were betting on getting these notes converted to shares and shorted and pushed this down to the current levels in anticipation of getting an additional 65% discount, we could see a short squeeze in a massive way.
Just a thought...
Slim...
While it might be pure manipulation, I believe that someone or a fund (Investor) took a position.
Clearly an indication of how close we are to fruition.
Top right corner...August 17, 2021
BF Borgers tops list of new SEC clients again
For the second quarter in a row, Lakewood, Colorado-based BF Borgers has topped the list of auditors bringing on new Securities and Exchange Commission clients, while Big Four firm Ernst & Young led the way among large firms for the first three months of the year.
https://www.accountingtoday.com/news/bf-borgers-tops-list-of-new-sec-clients-again
BF Borgers is definitely not a fly by night auditor...
Helen Sabzevari
https://www.bristolwhoswho.com/helen-sabzevari/
Jerry...Please refer to the "note" on page 18 at the bottom of Item 5 B under the box of subsidiaries.
Moxy...Please refer to the "note" on page 18 at the bottom of Item 5 B under the box of subsidiaries.
At BF Borgers CPA, PC we have built our practice by providing exceptional service to our clients through our commitment to our firm culture and values based on the three underlying principals Professionalism, Responsiveness, Quality.
www.bfbcpa.us/about-our-firm/
8K Filed
Item 8.01 Other Events.
On April 19, 2021 Regen Biopharma, Inc. (the “Company”) executed an engagement letter with BF Borgers CPA PC ( “Borgers”), the Company’s independent registered public accounting firm, the purpose of which was to retain Borgers to perform an audit of the Company’s balance sheet as of September 30, 2019, the related statement of operations, stockholders' equity (deficit), and cash flows for the year then ended, and the related notes (collectively referred to as the "Financial Statements") for inclusion in a Form 10-K for the year ended September 30, 2019 to be filed with the United States Securities and Exchange Commission (“2019 10-K”) .
The commencement of this audit of the Company’s Financial Statements is the first step in curing the Company’s delinquency with regard to periodic reports required to be filed with the United States Securities and Exchange Commission.
8K Out